Scalp lesions in cancer patients
Pro Research Analysisby 
Searched over 200M research papers
Types of Scalp Lesions in Cancer Patients
Scalp lesions in cancer patients can arise from primary scalp malignancies, metastatic disease from distant cancers, or as side effects of cancer therapies. The most common primary scalp cancers include squamous cell carcinoma, basal cell carcinoma, and melanoma, which can sometimes invade deeper structures like the calvarium and even the dura or brain tissue 1479. Metastatic lesions to the scalp are rare but have been reported from breast, gastric, and cervical cancers, among others 2568+1 MORE.
Primary Scalp Malignancies: Presentation and Management
Primary malignant tumors of the scalp often present as nodules, ulcers, or crusted lesions. These tumors can be locally aggressive, sometimes invading the skull (calvarium) and requiring complex surgical management. Aggressive surgical resection, including partial or full-thickness calvarial removal, is often necessary for local control, especially when the tumor invades bone but not the medullary space 147. Reconstruction typically involves plastic surgery, often using free tissue transfer, and is associated with good outcomes and acceptable complication rates 47. Long-term local control rates are high with these approaches 17.
Metastatic Scalp Lesions: Rare but Significant
Metastatic involvement of the scalp is uncommon and can be the first or only sign of widespread disease progression. Breast cancer is the most frequently reported source of scalp metastases, but such cases remain extremely rare 256. These lesions may present as firm, non-tender nodules and require thorough radiologic and pathologic evaluation to distinguish them from primary skin tumors or other neoplasms 256. Other cancers, such as gastric and cervical cancer, can also metastasize to the scalp, though this is exceedingly rare and often signals advanced disease 810. In some cases, scalp metastasis may be the only detectable site of distant spread, including in occult breast cancer .
Therapy-Related Scalp Lesions: EGFR Inhibitor-Induced Dermatosis
Cancer therapies, particularly epidermal growth factor receptor (EGFR) inhibitors, can induce inflammatory scalp conditions such as erosive pustular dermatosis of the scalp (EPDS). EPDS presents with erosions, crusts, pustules, and can lead to scarring alopecia. It typically appears within a few months of starting EGFR inhibitor therapy and may be widespread, unlike primary EPDS which is usually localized . Management often includes high-potency topical corticosteroids and oral tetracyclines, with about half of patients experiencing regression of lesions .
Diagnostic and Management Considerations
Scalp lesions in cancer patients require careful evaluation. For primary tumors, aggressive surgical management with multidisciplinary involvement is key to achieving local control and minimizing recurrence 147. For metastatic lesions, a comprehensive workup including imaging and immunohistochemistry is essential to guide treatment and distinguish metastases from primary skin cancers or benign lesions 2568+1 MORE. Therapy-induced lesions should be recognized early, and prophylactic or early anti-inflammatory treatment may help reduce severity .
Conclusion
Scalp lesions in cancer patients can result from primary malignancies, metastatic disease, or as side effects of cancer therapies. While primary scalp cancers are managed effectively with aggressive surgery and reconstruction, metastatic lesions—though rare—require thorough diagnostic workup and may indicate advanced disease. Therapy-induced scalp conditions, such as those caused by EGFR inhibitors, are increasingly recognized and should be managed promptly to prevent complications. Early recognition and a multidisciplinary approach are essential for optimal outcomes in this diverse patient population.
Sources and full results
Most relevant research papers on this topic